Basic calcium phosphate crystal deposition diseases

Last updated: June 13, 2023

CME information and disclosurestoggle arrow icon

To see contributor disclosures related to this article, hover over this reference: [1]

Physicians may earn CME/MOC credit by reading information in this article to address a clinical question, and then completing a brief evaluation, in which they will identify their question and report the impact of any information learned on their clinical practice.

AMBOSS designates this Internet point-of-care activity for a maximum of 0.5 AMA PRA Category 1 Credit(s)™. Physicians should claim only credit commensurate with the extent of their participation in the activity.

For answers to questions about AMBOSS CME, including how to redeem CME/MOC credit, see “Tips and Links” at the bottom of this article.

Summarytoggle arrow icon

Basic calcium phosphate (BCP) crystal deposition diseases are an uncommon form of crystalline arthropathy. BCP crystals include several different types of calcium phosphate crystals, such as partially carbonate-substituted hydroxyapatite, octacalcium phosphate, and tricalcium phosphate. These crystals are deposited in joints or in periarticular structures, causing BCP-associated arthritis (including Milwaukee shoulder syndrome) and calcific tendinitis. The underlying etiology of articular and periarticular BCP crystal deposition is unknown, but risk factors include female sex, joint trauma, and various metabolic abnormalities. The presentation and management of BCP-associated osteoarthritis are similar to that of age-related osteoarthritis. Milwaukee shoulder syndrome and acute calcific tendinitis manifest with joint pain and swelling, most commonly of the shoulder or other large joints. Diagnosis is based on clinical and radiological findings. Synovial fluid analysis may be helpful in excluding differential diagnoses (e.g., acute gout, pseudogout, septic arthritis) but rarely identifies the small, nonbirefringent BCP crystals. Management is primarily supportive and includes pain relief for acute episodes, physical dissolution of crystals by various methods (e.g., needle aspiration, ultrasound therapy), and surgery in severe cases.

Etiologytoggle arrow icon

The underlying etiology that results in BCP crystal deposition within joints and periarticular tissue remains poorly understood. The following factors are associated with an increased risk of developing BCP crystal deposition diseases: [2][3][4]

Pathophysiologytoggle arrow icon

The pathophysiology of BCP crystal deposition diseases is complex and not yet fully understood. BCP crystals appear to cause joint degeneration by inducing both inflammatory and catabolic processes. [2][7]

Subtypes and variantstoggle arrow icon

There are three main subtypes of BCP crystal deposition disease, all of which vary in their clinical presentation and diagnosis.

Basic calcium phosphate-associated osteoarthritistoggle arrow icon

BCP-associated osteoarthritis (OA) is osteoarthritis associated with the intraarticular deposition of BCP crystals. [7]

BCP-associated arthropathies typically affect large joints. [2]

Milwaukee shoulder syndrometoggle arrow icon

Milwaukee shoulder syndrome is a subtype of BCP-associated OA characterized by a noninflammatory osteoclast-mediated destructive arthritis of the shoulder joint and commonly accompanied by non-inflammatory joint effusion and rotator cuff deficits. [3][7][9]

Milwaukee shoulder syndrome is associated with an extensive loss of articular cartilage, destruction of the humeral head, rotator cuff defects, large effusion, and small osteophytes. Conversely, OA is typically associated with prominent osteophytes, an intact rotator cuff, and humeral head sclerosis. [9]

Calcific tendinitistoggle arrow icon

Calcific tendinitis is an inflammatory tendinopathy and periarticular soft tissue inflammation associated with periarticular deposition of BCP crystals. [12]

Periarticular calcium deposits may be asymptomatic and detected incidentally. [2]

Diagnosticstoggle arrow icon

The diagnosis of BCP crystal deposition diseases is primarily based on clinical and radiological findings. See “Subtypes and variants” section for specific diagnostic studies. [2]

Differential diagnosestoggle arrow icon

References: [4][10]

The differential diagnoses listed here are not exhaustive.

Treatmenttoggle arrow icon

General principles

  • The management of BCP crystal deposition diseases is primarily supportive.
  • Treatment for BCP-associated OA is the same as for general OA (see “Treatment of osteoarthritis”).
  • Treatment for other BCP crystal deposition diseases should involve consultation with a rheumatologist.
    • Acute episodes: Treatment is focused on achieving pain relief.
    • Chronic disease: The aim is to physically dissolve the crystals using a variety of modalities.
    • Surgical intervention is a last resort.

Initial management (acute episodes) [2][3]

Subsequent management [2][3]

Referencestoggle arrow icon

  1. Rosenthal AK. Basic calcium phosphate crystal-associated musculoskeletal syndromes. Curr Opin Rheumatol. 2018; 30 (2): p.168-172.doi: 10.1097/bor.0000000000000477 . | Open in Read by QxMD
  2. Molloy ES, McCarthy GM. Hydroxyapatite deposition disease of the joint. Curr Rheumatol Rep. 2003; 5 (3): p.215-221.doi: 10.1007/s11926-003-0070-0 . | Open in Read by QxMD
  3. Rosenthal AK, Ryan LM. Nonpharmacologic and Pharmacologic Management of CPP Crystal Arthritis and BCP Arthropathy and Periarticular Syndromes. Rheum Dis Clin North Am. 2014; 40 (2): p.343-356.doi: 10.1016/j.rdc.2014.01.010 . | Open in Read by QxMD
  4. McCarthy GM, Dunne A. Calcium crystal deposition diseases — beyond gout. Nat Rev Rheumatol. 2018; 14 (10): p.592-602.doi: 10.1038/s41584-018-0078-5 . | Open in Read by QxMD
  5. Soares I, Mewar D. Milwaukee Shoulder Syndrome - an incidental finding but important cause of acute shoulder arthropathy. Rheumatology Advances in Practice. 2017; 1 (suppl_1).doi: 10.1093/rap/rkx011.005 . | Open in Read by QxMD
  6. Nadarajah CV, Weichert I. Milwaukee Shoulder Syndrome. Case Rep Rheumatol. 2014; 2014: p.1-4.doi: 10.1155/2014/458708 . | Open in Read by QxMD
  7. Dewachter L, Aerts P, Crevits I, Manelfe RD. Milwaukee shoulder syndrome.. JBR-BTR. 2012; 95 (4): p.243.doi: 10.5334/jbr-btr.629 . | Open in Read by QxMD
  8. Firestein GS. Kelley and Firestein's Textbook of Rheumatology. Elsevier ; 2017
  9. Beckmann NM. Calcium Apatite Deposition Disease: Diagnosis and Treatment. Radiol Res Pract. 2016; 2016: p.1-16.doi: 10.1155/2016/4801474 . | Open in Read by QxMD
  10. $Contributor Disclosures - Basic calcium phosphate crystal deposition diseases. None of the individuals in control of the content for this article reported relevant financial relationships with ineligible companies. For details, please review our full conflict of interest (COI) policy:.
  11. Atzeni F, Sarzi-Puttini P, Bevilacqua M. Calcium Deposition and Associated Chronic Diseases (Atherosclerosis, Diffuse Idiopathic Skeletal Hyperostosis, and Others). Rheum Dis Clin North Am. 2006; 32 (2): p.413-426.doi: 10.1016/j.rdc.2006.02.003 . | Open in Read by QxMD
  12. Hongsmatip P, Cheng KY, Kim C, Lawrence DA, Rivera R, Smitaman E. Calcium hydroxyapatite deposition disease: Imaging features and presentations mimicking other pathologies.. Eur J Radiol. 2019; 120: p.108653.doi: 10.1016/j.ejrad.2019.108653 . | Open in Read by QxMD

Icon of a lock3 free articles remaining

You have 3 free member-only articles left this month. Sign up and get unlimited access.
 Evidence-based content, created and peer-reviewed by physicians. Read the disclaimer